Kyowa Kirin Demonstrates Commitment to Real-world Evidence for POTELIGEO® (mogamulizumab) at EORTC 2023.
Systemic therapy approved for second-line treatment of adults with mycosis fungoides (MF) or Sézary syndrome…
Systemic therapy approved for second-line treatment of adults with mycosis fungoides (MF) or Sézary syndrome…
audax is designed to help banks compete in the digital age, pursue new digital business…
TAIPEI, Taiwan--(BUSINESS WIRE)--#CMC--Leveraging the superior conversion efficiency of N-type cells, the rise of cost-effective TOPCon…
VeriSilicon’s IP solutions optimized for demanding Robotics and AR/VR/MR applications SHANGHAI--(BUSINESS WIRE)--#3D--VeriSilicon (688521.SH) today announced…
Round led by Peak XV Partners (formerly Sequoia Capital India) and Elevation Capital with participation…
Utilizing EV (Electric Vehicle) Energy for Medical Services at Times of Disaster HAMAMATSU, Japan--(BUSINESS WIRE)--In…
Partnership with Everest Medicines will address a critical unmet medical need for patients with active…
--(BUSINESS WIRE)--Atomera Incorporated (Nasdaq: ATOM): WHO: Professor Hiu Yung Wong of San Jose University, Robert…
Supply chain group and operator of CHEP brand on track to meet 2025 Sustainability Targets…
Presentations demonstrate the need for molecular and immune profiling to make evidence-based treatment decisions and…